Skip to content
Screener

Similar metrics at other companies

StoneX Group Inc. logo
SNEXTotal trailing commission — Revenue
$7.6M+5.6%
SPX Technologies logo
SPXCRevenues — Revenue
$394M+22.0%
Oracle logo
ORCLCloud Revenues — Revenue
$9.91B+47.1%
Oracle logo
ORCLSoftware Revenues — Revenue
$6.82B-2.1%
Blue Owl Capital logo
OWLPerformance revenues — Revenue
$6.07M-3.9%
EAT
EATFranchise revenues — Revenue
$14.7M+21.5%

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001823239-26-000059
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$51,442$47,397$117,279$94,247
Cost of revenue30,79239,62962,92878,754
Gross profit20,6507,76854,35115,493
Operating expenses:
Selling, general and administrative32,07038,71561,16278,279
Research and development3,7024,8827,5919,770
Goodwill impairment30,44942,884
Restructuring(33)2,845

Item 1. Financial Statements

FAQ

What is Maravai LifeSciences Holdings, Inc.'s trilink — revenue?
Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — revenue of $34.67M in Q2 2026.
How has Maravai LifeSciences Holdings, Inc.'s trilink — revenue changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s trilink — revenue increased by 11.5% year-over-year, from $31.09M to $34.67M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s trilink — revenue?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s trilink — revenue has grown at a -36.0% compound annual growth rate (CAGR), from $712.52M to $119.79M.
What does trilink — revenue mean?
This represents the total gross income generated by the Nucleic Acid Production segment through the sale of products and services. It serves as a primary indicator of market demand for the company's core life sciences offerings and therapeutic support programs.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude